{
    "clinical_study": {
        "@rank": "56980", 
        "acronym": "IBEP", 
        "arm_group": [
            {
                "arm_group_label": "Intensive Behavioral Modification", 
                "arm_group_type": "Experimental", 
                "description": "intensive dietary counseling, increased activity, lactation consult"
            }, 
            {
                "arm_group_label": "Routine care", 
                "arm_group_type": "No Intervention", 
                "description": "standard dietary counseling"
            }
        ], 
        "brief_summary": {
            "textblock": "The IBEP study is a randomized control trial of a healthy lifestyle intervention program for\n      women with gestational diabetes. The primary aim of the study is to evaluate whether women\n      with gestational diabetes enrolled in an intensive behavioral educational program (IBEP)\n      demonstrate lower mean fasting glucose levels measured by 2 hour 75 gram oral glucose\n      tolerance test (OGTT) at 6 weeks postpartum compared to women with gestational diabetes who\n      undergo routine gestational diabetes education and counseling."
        }, 
        "brief_title": "The IBEP Study: an Intervention for Lifestyle Modification in Women With Gestational Diabetes", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Gestational Diabetes", 
            "Weight Gain During Pregnancy", 
            "Weight Loss After Pregnancy"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Weight Gain", 
                "Weight Loss", 
                "Diabetes, Gestational"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  women diagnosed with gestational diabetes between 20 and 34 weeks gestation\n\n        Exclusion Criteria:\n\n          -  women on chronic steroid therapy\n\n          -  women with a diagnosis of GDM <20 weeks or >34 weeks"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "45 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 8, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01858233", 
            "org_study_id": "IBEP"
        }, 
        "intervention": {
            "arm_group_label": "Intensive Behavioral Modification", 
            "description": "Intensive dietary counseling, increased physical activity, lactation counseling", 
            "intervention_name": "Intensive Behavioral Modification", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "Gestational diabetes", 
        "lastchanged_date": "May 16, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Philadelphia", 
                    "country": "United States", 
                    "state": "Pennsylvania", 
                    "zip": "19104"
                }, 
                "name": "University of Pennsylvania"
            }, 
            "investigator": [
                {
                    "last_name": "Celeste P Durnwald, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Kelly Allison, PhD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The IBEP Study: a Randomized Control Trial of an Educational Intervention for Lifestyle Modification in Women With Gestational Diabetes.", 
        "overall_contact": {
            "email": "celeste.durnwald@uphs.upenn.edu", 
            "last_name": "Celeste P Durnwald, MD", 
            "phone": "215-662-6913"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To evaluate mean fasting glucose levels measured by 2 hour 75 gram oral glucose tolerance test (OGTT) at 6 weeks in women enrolled in an intensive behavioral educational program compared to women with GDM who undergo routine GDM education and counseling.", 
            "measure": "The IBEP Study", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01858233"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "To evaluate the amount of weight lost in women enrolled in an intensive behavioral program and whether it correlates with more favorable lipid profiles at 6 weeks postpartum.", 
            "measure": "The IBEP Study", 
            "safety_issue": "No", 
            "time_frame": "2 years"
        }, 
        "source": "University of Pennsylvania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Pennsylvania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}